Menu

Gilead Sciences, Inc. GILD

Full chart Compare
Set alert

Price alert · GILD

All alert types
166.89 USD -0.68 (-0.41%)

At closeNov 6, 2026, 5:31 PM EST

166.89 0.00 0.00%

After hours · Nov 6, 5:31 PM ET

164.00 Day range 169.03
118.15 52-week range 174.48
YTD
+35.97%
1 year
+35.24%

Revenue & Expenses

Revenue by
Biktarvy → Revenue: $14.33BRevenue → Gross Profit: $23.21BGross Profit → Net Income: $8.51BGross Profit → Selling, General & Admin: $5.71BGross Profit → Research & Development: $5.80BRevenue → Cost of Revenue: $6.23BGross Profit → Interest Expense: $1.02BGross Profit → Other Expenses: $881.00MGross Profit → Income Tax: $1.29BDescovy → Revenue: $2.76BGenvoya → Revenue: $1.50BYescarta → Revenue: $1.50BTrodelvy → Revenue: $1.40BSofosbuvir/Velpatasvir → Revenue: $1.27BOther → Revenue: $6.69BGross Profit$23.21BCost of Revenue$6.23BNet Income$8.51BSelling, General & Admin$5.71BResearch & Development$5.80BInterest Expense$1.02BOther Expenses$881.00MIncome Tax$1.29BRevenue$29.44BBiktarvy$14.33BDescovy$2.76BGenvoya$1.50BYescarta$1.50BTrodelvy$1.40BSofosbuvir/Velpatasvir$1.27BOther$6.69B

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

GILD annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
29.44B28.75B27.12B27.28B27.30B
29.44B28.75B27.12B27.28B27.30B
6.23B6.25B6.50B5.66B6.60B
23.21B22.50B20.62B21.62B20.70B
13.19B20.84B13.01B14.29B10.79B
5.80B5.91B5.72B4.98B4.60B
5.77B6.09B6.09B5.67B5.25B
10.02B1.66B7.61B7.33B9.92B
1.02B977.00M944.00M935.00M1.00B
1.29B211.00M1.25B1.25B2.08B
8.51B480.00M5.67B4.59B6.22B
8.51B480.00M5.67B4.59B6.22B
8.51B480.00M5.67B4.59B6.22B
8.51B480.00M5.61B4.57B6.20B
6.840.384.543.664.96
6.840.384.543.664.96
6.780.384.503.644.93
3.163.083.002.922.84
10.82B1.67B7.86B6.78B9.30B
10.82B1.67B7.86B6.78B9.30B
1.24B1.25B1.25B1.25B1.26B
1.25B1.25B1.26B1.26B1.26B